The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
Open Access
- 1 February 2018
- journal article
- research article
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 12, 61-67
Abstract
Background: Tumor necrosis factor alpha (TNFα) is a key cytokine in both the pathogenesis of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) and the host defense against tuberculosis (TB). Consequently, anti-TNFα medications result in an increased risk of latent TB infection (LTBI) reactivation. Here, we sought to evaluate the factors affecting the results of QuantiFERON-TB Gold In-Tube (QFT-GIT) assay as a screening tool for LTBI. Methods: We conducted an observational, retrospective study in patients with IBD and RA who underwent LTBI screening using QFT-GIT at UMass Memorial Medical Center between 2008 and 2016 prior to initiation of anti-TNF medications. Results: We included 107 and 89 patients with IBD and RA, respectively. We found that a higher proportion of IBD patients had indeterminate QFT-GIT result compared to RA patients. Furthermore, we found that the majority of patients with indeterminate results were tested during an acute flare of IBD (88%) and while taking corticosteroids. Of all patients receiving ≥20 mg equivalent prednisone dose (n=32), 63% resulted in indeterminate QFT-GIT, compared to only 6% indeterminate testing in patients receiving P Conclusion: We observed that high-dose corticosteroids may affect QFT-GIT outcomes leading to a high proportion of indeterminate results. We propose that IBD patients should be tested prior to initiation of corticosteroids to avoid equivocal results and prevent potential delays in initiation of anti-TNF medications.Keywords
This publication has 27 references indexed in Scilit:
- ACR/EULAR 2010 rheumatoid arthritis classification criteriaRheumatology, 2012
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ RegistryAmerican Journal of Gastroenterology, 2012
- Macrophages and control of granulomatous inflammation in tuberculosisMucosal Immunology, 2011
- Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseasesEuropean Journal of Clinical Investigation, 2011
- TNFα blockade in human diseases: An overview of efficacy and safetyClinical Immunology, 2008
- Disseminated tuberculosis after anti-TNFα treatmentThe Lancet, 2007
- Influence of Bacille Calmette-Guerin Vaccination on Size of Tuberculin Skin Test Reaction: To What Size?Clinical Infectious Diseases, 2005
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Role of Cytokines in the Pathogenesis of Inflammatory Bowel DiseaseAnnual Review of Medicine, 2000
- An Address on Bacteriological ResearchBMJ, 1890